{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T09:42:24Z","timestamp":1694857344788},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Dry eye disease is a common eye disease mainly manifests with eye fatigue, foreign body sensation, dry and astringent eyes and other symptoms. Growing evidence shows that qiming granule may have beneficial effects on the clinical treatment of dry eye disease. However, no systematic review and meta-analysis collate and assess these clinical evidences. The purpose of this study protocol is to provide a comprehensive and reliable evaluation of the clinical evidence of qiming granule in the treatment of DED.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and analysis:<\/jats:title>\n            <jats:p>Three English database and 4 Chinese databases other sources will be searched. Two methodological trained researchers will read the title, abstract and full texts and independently select the qualified literature according to inclusion and exclusion criteria. After assessment of the risk of bias and data extraction, we will conduct meta-analyses for outcomes including central macular thickness, optimum corrected vision, overall effect rates and adverse effects. The heterogeneity of data will be investigated by Cochrane X<jats:sup>2<\/jats:sup> and <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup> tests. We build 3 hypotheses for subgroup analysis according to the guidance for a credible subgroup effect: Disease status at baseline, duration of intervention, type of concomitant medication. Sensitivity analysis will be conducted to evaluate the stability of the results. Then publication bias assessment will be conducted by funnel plot analysis and Egger test. Finally, we will use the Grading of Recommendations Assessment, Development and Evaluate system to evaluate the quality of evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The results of our research will be published in a peer-reviewed journal.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our study is the first meta-analysis to evaluate the clinical efficacy and safety of qiming granule in the treatment of DED. It will provide more options for clinical treatment of the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PROSPERO registration number:<\/jats:title>\n            <jats:p>CRD42018109183.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017121","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T08:44:29Z","timestamp":1569487469000},"page":"e17121","source":"Crossref","is-referenced-by-count":2,"title":["The efficacy and safety of qiming granule in dry eye disease"],"prefix":"10.1097","volume":"98","author":[{"given":"Maoyi","family":"Yang","sequence":"first","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Hu","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rensong","family":"Yue","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangjun","family":"Yang","sequence":"additional","affiliation":[{"name":"Pi Wei Institute, Guangzhou University of Chinese Medicine, Guangzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","article-title":"Prevalence of diagnosed dry eye disease in the united states among adults aged 18 years and older","volume":"182","author":"Farrand Kimberly","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R2-20230915","first-page":"81","article-title":"Attention to the construction of management system for dry eye chronic diseases","volume":"54","author":"Liu","year":"2018","journal-title":"Chin J Ophthalmol Med"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","article-title":"Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life","volume":"157","author":"Paulsen Adam","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop 2007","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"Moss","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40266-015-0277-6","article-title":"Therapeutic strategies to treat dry eye in an aging population","volume":"32","author":"Ezuddin","year":"2015","journal-title":"Drugs Aging"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.otc.2005.03.012","article-title":"The diagnosis and management of dry eyes","volume":"38","author":"Gilbard","year":"2005","journal-title":"Otolaryngol Clin North Am"},{"key":"R8-20230915","first-page":"1","article-title":"Drugs for some common eye disorders[J]","volume":"5","author":"Listed","year":"2007","journal-title":"Treatment Guidelines from the Medical Letter"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2013-304072","article-title":"Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease","volume":"98","author":"Sacchetti","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11655-009-0384-5","article-title":"Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial","volume":"15","author":"Luo","year":"2009","journal-title":"Chin J Integr Med"},{"key":"R13-20230915","first-page":"207","article-title":"To observe the clinical efficacy of Qiming Granule in the treatment of dry eye in type 2 diabetes mellitus","volume":"17","author":"Song","year":"2019","journal-title":"Guide China Med"},{"key":"R14-20230915","first-page":"103","article-title":"Clinical observation of qiming granule in the treatment of dry eye in type 2 diabetes mellitus","volume":"5","author":"Wang","year":"2018","journal-title":"Electr J Clin Med Literat"},{"key":"R15-20230915","first-page":"26","article-title":"Clinical observation of qiming granule combined with flumiron eye drops in the treatment of moderate and severe dry eye in children","volume":"39","author":"Ren","year":"2018","journal-title":"Shaanxi J Tradl Chin Med"},{"key":"R16-20230915","first-page":"193","article-title":"Clinical efficacy and safety of Qiming granule combined with polyethylene glycol in the treatment of dry eye","volume":"20","author":"Du","year":"2018","journal-title":"J Liaoning Univ Tradl Chin Med"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"142","DOI":"10.56645\/jmde.v6i14.284","article-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"6","author":"Tarsilla","year":"2008","journal-title":"J Multidisciplinary Evaluation"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"15391558","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Ann Intern Med"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:33:58Z","timestamp":1694817238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017121"}},"subtitle":["Protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":23,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017121","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}